Judith A. James, MD, PhD

Trials

Studies that name Judith A. James, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:43 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05236270 · CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)

  University of Oklahoma · completed · COVID-19, Vaccine Refusal
• Ph2
  NCT05000216 · COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

  National Institute of Allergy and Infectious Diseases (NIAID) · terminated · Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris · study chair
• N/A
  NCT04870307 · Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

  University of Oklahoma · completed · Covid19
• Ph2
  NCT01946880 · Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

  National Institute of Allergy and Infectious Diseases (NIAID) · terminated · Systemic Lupus Erythematosus, SLE · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Administrative Core
  U54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JUDITH A JAMES · fiscal years 2013 to 2026
  Named on NCT05236270, NCT04870307